TCS and Infosys added twelve $100 million+ clients each post-pandemic, outpacing Wipro and HCLTech's seven. While TCS and Infosys boasted 62 and 40 such clients respectively by 2023-24, Wipro and HCLTech had 22 each. Large deal wins slowed across the industry due to reduced spending and global uncertainties.
Related news
HSBC has downgraded India's outlook to 'Neutral' from 'overweight', setting a target of Rs 85,990 for 2025 for BSE Sensex. The firm cites lower corporate profits and high valuations as key concerns.
Adani Ports has withdrawn its request for a $553 million loan from the US International Development Finance Corporation (IDFC) for a Sri Lankan port project. Facing US fraud allegations, the company will now self-fund the Colombo West International Terminal development, originally slated to begin operations this month but now expected by early 2025.
Rohan Mirchandani, the 42-year-old co-founder of Epigamia, passed away from a sudden cardiac arrest. He established the company in 2013, introducing flavored Greek yogurt to India. Epigamia's leadership and board, including Mirchandani's family, will continue his work. His death is a loss to the entrepreneurial community.
Banks are offering better deposit rates to attract customers amid liquidity shortages. IDBI Bank launched a scheme for individuals aged 80 and above, with higher interest rates. Similarly, Bank of Baroda introduced a liquid fixed deposit scheme allowing withdrawals in units of Rs 1,000, with extra benefits for seniors.
On Tuesday, Unimech Aerospace and Manufacturing Ltd shares debuted on the stock exchange with a notable 90% premium above its Rs 785 issue price, listing at Rs 1,491 on the BSE and Rs 1,460 on the NSE. The company's IPO was significantly oversubscribed, achieving a market capitalisation of Rs 6,956.20 crore.
Grant Lee's AI startup Gamma is thriving with just 28 employees, achieving significant revenue and profitability. Many AI-driven startups are leveraging technology to maximize efficiency and reduce the need for large teams and funding. The trend raises questions about the future of venture capital investment in such lean and efficient companies.
Aurobindo Pharma's subsidiary, CuraTeQ Biologics, received a positive CHMP opinion for its filgrastim biosimilar, Zefylti, intended to treat neutropenia and mobilize peripheral progenitor cells. Zefylti is CuraTeQ's first biosimilar to receive this positive opinion. Three additional biosimilars are currently under review with EMA and UK-MHRA, expected to be available next year.
Automobile exports from India saw a notable 19% increase in 2024, reaching 50,98,810 units compared to 42,85,809 units in 2023. The growth was driven by strong demand for two-wheelers, passenger vehicles, and commercial vehicles, particularly in emerging markets such as Latin America and Africa.
NPCI extends the deadline for PhonePe and Google Pay to lower their market share in UPI by two years, lifting the onboarding limit for WhatsApp. Despite new players, PhonePe and Google Pay dominate the market. NPCI aims to avoid single-point failure risk and supports diverse UPI app growth.
Dr. Reddy's Laboratories has refuted media reports alleging a 25% reduction in workforce costs. The Hyderabad-based pharmaceutical giant dismissed claims of layoffs targeting high-earning employees and voluntary retirement offers for older staff, particularly in R&D.